Global DNA Diagnostics Market Size Study, by Product Type, by Technology, by Applications, by End-Users, and Regional Forecasts 2022-2032

Description

Global DNA diagnostics market is valued at approximately USD 25.15 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.8% over the forecast period 2024-2032. DNA diagnostics, a groundbreaking methodology in medical diagnostics, empowers healthcare professionals to detect various diseases, including cancer, infectious diseases, and myogenic disorders, and to tailor appropriate treatments. This technique is integral to clinical diagnostic confirmation and prenatal diagnostics, stemming from advancements in the Human Genome Project, which unveiled numerous disease-causing agents. Technological progress has significantly enhanced DNA diagnostic platforms and techniques. Prominent technologies in DNA diagnostics encompass polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry. These technologies facilitate crucial processes like sample preparation and DNA isolation. The continuous improvement in these methodologies drives the market's growth. Furthermore, the application of DNA diagnostics in prenatal diagnostics and clinical confirmations has further accelerated market expansion.

The DNA diagnostics market is poised for substantial growth in the foreseeable future, propelled by innovations in product design and technology. This shift has encouraged medical professionals and researchers to transition from traditional diagnostic methods to personalized medicines, which will positively influence market growth. Next-generation sequencing (NGS) stands out as a potent tool for decoding numerous human diseases, including various cancers. NGS reduces sequencing costs and enhances throughput, significantly impacting the DNA diagnostics market.

The market is segmented based on product type, technology, application, end-users, and geography. Instruments, reagents, and service & software constitute the product type segmentation, with instruments holding the dominant share due to enhanced healthcare facilities, user-friendly features, competitive cost structure, and growing demand. The service & software segment is projected to grow steadily, driven by technological advancements and IT integration in DNA diagnostics.

PCR dominates the technology segment owing to its extensive use in diagnostic procedures like sample preparation and DNA separation. The market is also segmented by application into oncology, infectious diseases, and myogenic disorders, with oncology leading due to the rising incidence of cancer and an aging population.

The key regions considered for the global DNA Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the DNA Diagnostics Market in terms of revenue. The market growth in the region is being attributed to factors including high DNA diagnostics adoption rates and the prevalence of chronic and infectious diseases. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by a large and growing population that creates high demand for healthcare services. Governments in the region are also increasingly funding research and development of DNA testing technologies. This, combined with a rising burden of chronic diseases like cancer, creates lucrative prospects for market growth over the anticipated years.

Major market players included in this report are:

Illumina, Inc.
Bayer Diagnostic
Cephide Inc.
Thermo Fisher Scientific
Gen-probe Inc. (Hologic)
Johnson and Johnson
Bio-Rad Laboratories
Roche Diagnostics
Novartis
Abbott Laboratories

The detailed segments and sub-segment of the market are explained below:

By Product Type

Instruments
Reagents
Service & Software

By Technology

PCR
Microarray
In-situ Hybridization
Sequencing Technology
Mass Spectrometry
Others

By Applications

Oncology
Infectious Disease
Myogenic Disorder
Clinical Diagnostic Confirmation
Prenatal Diagnostics
Pre-implantation Diagnostics
Others

By End-Users

Point of Care
Diagnostic Center
Self-Testing/OTC

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global DNA Diagnostics Market Executive Summary

1.1. Global DNA Diagnostics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product Type
- 1.3.2. By Technology
- 1.3.3. By Applications
- 1.3.4. By End-Users
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global DNA Diagnostics Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global DNA Diagnostics Market Dynamics

3.1. Market Drivers
- 3.1.1. Technological Advancements in DNA Diagnostics
- 3.1.2. Rising Adoption of Personalized Medicine
- 3.1.3. Increasing Prevalence of Chronic and Infectious Diseases
3.2. Market Challenges
- 3.2.1. High Costs of DNA Diagnostic Technologies
- 3.2.2. Regulatory and Ethical Concerns
3.3. Market Opportunities
- 3.3.1. Expansion in Emerging Markets
- 3.3.2. Integration of AI and Big Data in DNA Diagnostics
- 3.3.3. Development of Next-Generation Sequencing

Chapter 4. Global DNA Diagnostics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global DNA Diagnostics Market Size & Forecasts by Product Type 2022-2032

5.1. Segment Dashboard
5.2. Global DNA Diagnostics Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Instruments
- 5.2.2. Reagents
- 5.2.3. Service & Software

Chapter 6. Global DNA Diagnostics Market Size & Forecasts by Technology 2022-2032

6.1. Segment Dashboard
6.2. Global DNA Diagnostics Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. PCR
- 6.2.2. Microarray
- 6.2.3. In-situ Hybridization
- 6.2.4. Sequencing Technology
- 6.2.5. Mass Spectrometry
- 6.2.6. Others

Chapter 7. Global DNA Diagnostics Market Size & Forecasts by Applications 2022-2032

7.1. Segment Dashboard
7.2. Global DNA Diagnostics Market: Applications Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Oncology
- 7.2.2. Infectious Disease
- 7.2.3. Myogenic Disorder
- 7.2.4. Clinical Diagnostic Confirmation
- 7.2.5. Prenatal Diagnostics
- 7.2.6. Pre-implantation Diagnostics
- 7.2.7. Others

Chapter 8. Global DNA Diagnostics Market Size & Forecasts by End-Users 2022-2032

8.1. Segment Dashboard
8.2. Global DNA Diagnostics Market: End-Users Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Point of Care
- 8.2.2. Diagnostic Center
- 8.2.3. Self Testing/OTC

Chapter 9. Global DNA Diagnostics Market Size & Forecasts by Region 2022-2032

9.1. North America DNA Diagnostics Market
- 9.1.1. U.S. DNA Diagnostics Market
  - 9.1.1.1. Product Type breakdown size & forecasts, 2022-2032
  - 9.1.1.2. Technology breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Applications breakdown size & forecasts, 2022-2032
  - 9.1.1.4. End-Users breakdown size & forecasts, 2022-2032
- 9.1.2. Canada DNA Diagnostics Market
  - 9.1.2.1. Product Type breakdown size & forecasts, 2022-2032
  - 9.1.2.2. Technology breakdown size & forecasts, 2022-2032
  - 9.1.2.3. Applications breakdown size & forecasts, 2022-2032
  - 9.1.2.4. End-Users breakdown size & forecasts, 2022-2032
9.2. Europe DNA Diagnostics Market
- 9.2.1. U.K. DNA Diagnostics Market
- 9.2.2. Germany DNA Diagnostics Market
- 9.2.3. France DNA Diagnostics Market
- 9.2.4. Spain DNA Diagnostics Market
- 9.2.5. Italy DNA Diagnostics Market
- 9.2.6. Rest of Europe DNA Diagnostics Market
9.3. Asia-Pacific DNA Diagnostics Market
- 9.3.1. China DNA Diagnostics Market
- 9.3.2. India DNA Diagnostics Market
- 9.3.3. Japan DNA Diagnostics Market
- 9.3.4. Australia DNA Diagnostics Market
- 9.3.5. South Korea DNA Diagnostics Market
- 9.3.6. Rest of Asia Pacific DNA Diagnostics Market
9.4. Latin America DNA Diagnostics Market
- 9.4.1. Brazil DNA Diagnostics Market
- 9.4.2. Mexico DNA Diagnostics Market
- 9.4.3. Rest of Latin America DNA Diagnostics Market
9.5. Middle East & Africa DNA Diagnostics Market
- 9.5.1. Saudi Arabia DNA Diagnostics Market
- 9.5.2. South Africa DNA Diagnostics Market
- 9.5.3. Rest of Middle East & Africa DNA Diagnostics Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Bayer Diagnostic
- 10.3.2. Cephide Inc.
- 10.3.3. Gen-probe Inc. (Hologic)
- 10.3.4. Johnson and Johnson
- 10.3.5. Bio-Rad Laboratories
- 10.3.6. Novartis
- 10.3.7. Abbott Laboratories
- 10.3.8. Illumina, Inc.
- 10.3.9. Roche Diagnostics
- 10.3.10. Thermo Fisher Scientific

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes